Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vitamin D Deficiency 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Vitamin D3 1Prostatic Neoplasms 1Pathologic Processes 1Pain 1Neuroma 1Musculoskeletal Diseases 1Multiple Sclerosis, Relapsing-Remitting 1Lymphoma, Follicular 1Liver Neoplasms 1Insulin Resistance 1Infertility, Female 1Hematologic Neoplasms 1Glioblastoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Cancer Pain 1Cachexia 1Breast Neoplasms 1

Interventions

Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vitamin D3 × Cholecalciferol × Clear all
NCT03389659 2018-01-03

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
750 enrolled

Vitamin D3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡